跳至主要内容
临床试验/NCT07731217
NCT07731217已完成4 期

INTRAVENOUS DEXAMETHASONE VERSUS METHYLPREDNISOLONE IN WITH SEVERE ASTHMA EXACERBATION: A RANDOMISED, OPEN-LABEL, SINGLE-CENTRE STUDY

Istanbul Medeniyet University1 个研究点 分布在 1 个国家目标入组 129 人开始时间: 2025年9月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
129
试验地点
1
主要终点
PRAM (Pediatric Respiratory Assessment Measure) Score at 4th Hour

研究概览

简要总结

The study aims to determine whether a two-day intravenous course of dexamethasone is non-inferior to a conventional five-day intravenous course of methylprednisolone in children presenting with severe asthma exacerbations. To answer this question, researchers randomly assign eligible children to receive either IV dexamethasone or IV methylprednisolone. The clinical response to the treatments is objectively evaluated and compared using the Pediatric Respiratory Assessment Measure (PRAM) score at the 4th hour of treatment and on the 2nd day following hospital discharge.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
2 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Aged between 2 and 18 years.
  • History of receiving salbutamol ± steroid treatment for two or more previous wheezing attacks, OR physician-diagnosed asthma.
  • Patients admitted to the Pediatric Emergency Department due to severe asthma exacerbation (Pediatric Respiratory Assessment Measure [PRAM] score ≥8).

排除标准

  • Patients with suspected or confirmed foreign body aspiration.
  • Patients with concurrent croup.
  • Presence of comorbidities (cardiovascular, neurological, malignancy, chronic kidney or lung disease).
  • Patients with pneumonia.
  • Patients with air leaks (pneumothorax, pneumomediastinum).
  • Patients requiring immediate Intensive Care Unit (ICU) admission.
  • Systemic steroid use within the last 8 weeks.
  • Failure to obtain informed consent.

结局指标

主要结局

PRAM (Pediatric Respiratory Assessment Measure) Score at 4th Hour

时间窗: At 4 hours after the initiation of treatment in the emergency department.

The PRAM score is a validated clinical scoring system used to assess asthma severity in children. It evaluates clinical signs including suprasternal retractions, scalene muscle contraction, air entry, wheezing, and O2 saturation. The total score ranges from 0 to 12, with higher scores indicating more severe respiratory distress.

PRAM Score on the 2nd Day Post-Discharge

时间窗: 2 days after discharge from the hospital

The PRAM score will be calculated to assess the patient's respiratory status during the follow-up visit. The total score ranges from 0 to 12, with higher scores indicating more severe respiratory distress.

次要结局

  • Total Number of Salbutamol Doses(Up to 14 days post-discharge.)
  • Hospitalization Rate(Up to 4 hours post-treatment initiation in the emergency department.)
  • Length of Hospital Stay(From hospital admission to hospital discharge (an expected average of 2 to 5 days))
  • Rate of Re-presentation to the Hospital(Within 14 days post-discharge)
  • Re-hospitalization Rate(Within 14 days post-discharge)
  • Incidence of Adverse Events(Up to 14 days post-discharge)

研究者

发起方
Istanbul Medeniyet University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Esen Besli

Assoc. Prof. Dr.

Istanbul Medeniyet University

研究点 (1)

Loading locations...

相似试验